Infections of the respiratory tract are mainly caused by viruses (e.g. SARS-CoV-2, influenza viruses, adenoviruses, RSV), but also bacteria (e.g. Legionella, Bordetella pertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae). Both the upper (e.g. nasal mucosa, paranasal sinuses) and the lower respiratory tracts (airways and bronchia) can be affected.
For Research Use Only. Not For Use In Diagnostic Procedures.
The individual product regulatory statements may vary, please refer to the instructions for use for more information.
wdt_ID | Method | Parameter | Substrate | Species/ Antigen |
---|---|---|---|---|
77 | IFA | antibodies against Bordetella pertussis IgA positive control |
Substrate | Species/ Antigen |
78 | IFA | antibodies against Bordetella pertussis IgG positive control |
||
79 | IFA | antibodies against Bordetella pertussis IgM positive control |
||
80 | IFA | Bordetella pertussis/parapertussis negative control |
||
81 | IFA | Bordetella pertussis |
bacterial smear |
Bordetella pertussis |
82 | ELISA | Bordetella pertussis incl. IgG/RF absorbent |
antigen-coated microplate wells |
inactivated Bordetella pertussis lysate |
83 | ELISA | Bordetella pertussis toxin |
antigen-coated microplate wells |
natives Bordetella pertussis toxin |
85 | ELISA | Bordetella pertussis toxin |
antigen-coated microplate wells |
natives Bordetella pertussis toxin |
86 | EUROLINE | Bordetella pertussis (FHA, PT, ACT separately) |
EUROLINE | |
87 | EUROLINE | positive control serum: IgG, human, 50x concentrated for Bordetella pertussis |
||
88 | IFA | Bordetella pertussis Bordetella parapertussis |
bacterial smears (2 BIOCHIPs per field) |
B. pertussis B. parapertussis |
89 | ELISA | Bordetella FHA |
antigen-coated microplate wells |
native Bordetella pertussis filamentous haemagglutinin |
90 | ELISA | Bordetella FHA |
antigen-coated microplate wells |
native Bordetella pertussis filamentous haemagglutinin |
91 | ELISA | Bordetella pertactin |
antigen-coated microplate wells |
native Bordetella pertussis pertactin |
92 | IFA | antibodies against Bordetella parapertussis IgA positive control |
||
93 | IFA | antibodies against Bordetella parapertussis IgG positive control |
||
94 | IFA | antibodies against Bordetella parapertussis IgM positive control |
||
95 | IFA | Bordetella parapertussis negative control |
||
96 | IFA | Bordetella parapertussis |
bacterial smear |
Bordetella parapertussis |
97 | IFA | antibodies against Legionella pneumophila serotypes 1 or 4 IgAGM positive control |
||
98 | IFA | BIOCHIP Sequence Legionella pneumophila serotypes 1 - 14 |
bacterial smears (1 BIOCHIP per serotype) verification BIOCHIP |
Legionella pneumophila |
99 | ELISA | Legionella pneumophila | antigen-coated microplate wells |
suspension of Legionella pneumophila serotypes 1-7 |
100 | ELISA | Legionella pneumophila | antigen-coated microplate wells |
suspension of Legionella pneumophila serotypes 1-7 |
101 | ELISA | Legionella pneumophila incl. IgG/RF absorbent |
antigen-coated microplate wells |
suspension of Legionella pneumophila serotypes 1-7 |
102 | IFA | Legionella pneumophila mixture 1-4-6-8 mixture 2-3-5-7 mixture 9-11-13 mixture 10-12-14 |
bacterial smears verification BIOCHIP (5 BIOCHIPs per field) |
Legionella pneumophila |
2024 EUROIMMUN US
Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Consent Preferences | Sitemap